Two weeks ago we discussed how to
find ligand-binding sites in RNA. Last week we wrote about how difficult it is
to find good ligands even for good binding sites in RNA. A recent open-access
paper in J. Med. Chem. by Christian Kersten and colleagues at Johannes
Gutenberg-University explores why targeting RNA is so tough.
The researchers were interested
in two well-characterized riboswitches, naturally occurring RNA elements that
bind to small molecules such as metabolites. Specifically, they chose to study
a riboswitch that binds to S-adenosyl methionine (SAM, structure here)
and a riboswitch that binds to prequeuosine-1 (PreQ1) and prequeuosine-0
(PreQ0).
Due to the phosphate backbone, RNA
is highly negatively charged. The researchers asked whether positively charged
moieties on ligands can serve as “electrostatic anchors” to generally improve affinity,
and if so whether this can lead to any design principles. Multiple biophysical techniques
were used to study the interactions of the two riboswitches with various
natural and synthetic ligands: surface plasmon resonance (SPR), isothermal
titration calorimetry (ITC), and microscale thermophoresis (MST).
In the case of the SAM-VI
riboswitch, the researchers compared the binding of SAM with closely related
molecules having either one fewer positive charge (S-adenosyl
homocysteine, or SAH) or synthetic ligands with the same or one more positive charge
than SAM. Not surprisingly, SAM has the highest affinity, binding 20-50 fold
more tightly than SAH. Further analysis suggested this is largely driven by an
increased association rate, in which the positive charge accelerates the kinetics of
binding. The driving energy for binding the ligands is enthalpic, but the favorable
electrostatic interactions for more positively charged ligands are largely
countered by an entropic penalty.
Similarly, the affinity of positively
charged PreQ1 for the PreQ1 riboswitch is higher than the
affinity of neutral PreQ0, though not dramatically. As in the case of the SAM-VI riboswitch, the association rate of the positively charged ligand is more rapid than that of the neutral ligand. Binding
for both ligands is highly enthalpic, with unfavorable entropy.
Previous reports had described other
synthetic ligands for the PreQ1 riboswitch, each with between one
and three cationic centers. However these ligands showed no binding by ITC,
questionable binding by MTC, and non-saturable, non-specific “loose binding” by
SPR. Positive charges alone are not sufficient for high affinity, specific binding.
So what does it all mean? While adding
positive charges can improve affinity of ligands for RNA, the increased
affinity is usually not dramatic due to enthalpy-entropy compensation. The researchers note that, even for good
ligands, the “thermodynamic binding profiles differ from typical protein-ligand
interactions, where enthalpic and entropic contributions are usually more balanced.”
Moreover, as we’ve noted, protein ligands
often gain significant affinity with entropic gains by displacing "high energy water" molecules, but such opportunities are likely less common on the polar surface of RNA.
The affinity and ligand efficiency of PreQ1 for its riboswitch are impressive, so clearly it
is possible for small drug-like ligands to bind tightly to RNA. But this
interaction is the product of countless eons of evolution. This careful paper suggests
why building similarly effective synthetic ligands for most RNA will be difficult.
No comments:
Post a Comment